Promising phase I results with KY-1005 pave way for phase II evaluation in atopic dermatitis July 30, 2018
Tonix to stop HONOR study of Tonmya for PTSD due to inadequate separation from placebo at week 12 July 30, 2018
BRD4 inhibitors patented by Luoxin Biotechnology Shanghai, Shandong Luoxin Pharmacy Group July 30, 2018
Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical identify A2A receptor antagonists July 30, 2018
RSS